Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-08-06 00:00:00 ET · period of report 2025-08-04 · accession 0001415889-25-021178 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-06 | 2025-08-04 | KNSA | Ragosa Mark | CFO | M - OptEx | $22.89 | +18.9K | 45.9K | +70% | +$432.4K |
| D | 2025-08-06 | 2025-08-04 | KNSA | Ragosa Mark | CFO | S - Sale+OE | $32.89 | -18.9K | 27.0K | -41% | -$621.3K |
| D | 2025-08-06 | 2025-08-04 | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -18.9K | 2,036 | -90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-08-04 | M | A | 18,889 | $22.89 | 45,898 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-08-04 | S | D | 18,889 | $32.89 | 27,009 | D | — | — | |
| 3 | Derivative | Share Option | 2025-08-04 | M | D | 18,889 | $0.00 | 2,036 | D | $22.89 · — to 2031-03-15 | 18,889 Class A Ordinary Share | (F2) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is March 16, 2021. |